Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA user fees

Executive Summary

The Natl. Assn. of Pharmaceutical Mfrs. requested in an Aug. 20 letter to FDA that the agency provide a 60 day comment period on its proposal for user fees, published in the Aug. Federa/Register ("The Pink Sheet" Aug. 12, p. 8). NAPM also said FDA should hold a regulatory hearing on the issue.

You may also be interested in...



Creating Healthcare Unicorns: Ex-Novartis CFO Shares Secret Sauce

Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.

Quick Listen: Scrip’s Five Must-Know Things

In this week's podcast edition of Scrip's Five Must-Know Things, hear about Sanofi’s rebates, Moderna’s business prospects, US views on coronavirus vaccine comparisons, Piot talk about virus variants, and new results for Amgen's asthma drug.

QUOTED. 8 March 2021. Martin Stürmer.

Right now, it appears that COVID-19 diagnostics are holding up against new variants of the virus being detected, but that may not always be the case scientists said at a recent webinar organized by Agena Bioscience. See what Martin Stürmer, laboratory head of IMD Labor in Frankfurt Germany, said about it here.

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel